The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

NCT04318626 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Post-stroke Cognitive Impairment
Neuroinflammation

Interventions

DRUG: PMPBB3
DRUG: THK5351

Sponsor

Chang Gung Memorial Hospital